Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by Aβ accumulation, tau pathology, and associated oxidative and inflammatory changes, including matrix metalloproteinase (MMP) involvement. This evidence concerns the gene MAPT and Alzheimer disease.